TERT promoter-driven adenovirus vector for cancer gene therapy via systemic injection
- 1 October 2007
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 362 (2) , 419-424
- https://doi.org/10.1016/j.bbrc.2007.08.001
Abstract
No abstract availableKeywords
Funding Information
- Japan Health Sciences Foundation
- Ministry of Education, Culture, Sports, Science and Technology (17016043)
- Ministry of Health, Labour and Welfare (17790123)
This publication has 31 references indexed in Scilit:
- Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administrationJournal of Controlled Release, 2007
- Adenoviral vectors—How to use them in cancer gene therapy?Virus Research, 2006
- Cancer‐specific targeting of an adenovirus‐delivered herpes simplex virus thymidine kinase suicide gene using translational controlThe Journal of Gene Medicine, 2006
- Adenoviral Gene Therapy in Head and Neck CancerDrug News & Perspectives, 2006
- Effect of Smad7 Expression on Metastasis of Mouse Mammary Carcinoma JygMC(A) CellsJNCI Journal of the National Cancer Institute, 2005
- Hypoxia- and radiation-activated Cre/loxP ‘molecular switch’ vectors for gene therapy of cancerGene Therapy, 2005
- Conditional expression of a suicide gene by the telomere reverse transcriptase promoter for potential post-therapeutic deletion of tumorigenesisCancer Science, 2005
- Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanomaCancer Gene Therapy, 2005
- Telomerase Catalytic Subunit Homologs from Fission Yeast and HumanScience, 1997
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994